• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
Thiazolidinedione use is associated with improved all-cause mortality compared with sulfonylureas among diabetic hemodialysis patients.与磺脲类药物相比，噻唑烷二酮类药物的使用与糖尿病血液透析患者全因死亡率的改善相关。
J Diabetes. 2014 Jul;6(4):381-3. doi: 10.1111/1753-0407.12115. Epub 2014 Feb 13.
2
Effectiveness and safety of long-term treatment with sulfonylureas in patients with neonatal diabetes due to KCNJ11 mutations: an international cohort study.KCNJ11 基因突变致新生儿糖尿病患者磺脲类药物长期治疗的有效性和安全性：一项国际队列研究。
Lancet Diabetes Endocrinol. 2018 Aug;6(8):637-646. doi: 10.1016/S2213-8587(18)30106-2. Epub 2018 Jun 4.
3
Association of Hemoglobin A1c Levels With Use of Sulfonylureas, Dipeptidyl Peptidase 4 Inhibitors, and Thiazolidinediones in Patients With Type 2 Diabetes Treated With Metformin: Analysis From the Observational Health Data Sciences and Informatics Initiative.血红蛋白 A1c 水平与二甲双胍治疗的 2 型糖尿病患者使用磺酰脲类、二肽基肽酶 4 抑制剂和噻唑烷二酮类药物的相关性：来自观察性健康数据科学和信息学倡议的分析。
JAMA Netw Open. 2018 Aug 3;1(4):e181755. doi: 10.1001/jamanetworkopen.2018.1755.
4
Secondary failure of glycemic control for patients adding thiazolidinedione or sulfonylurea therapy to a metformin regimen.在二甲双胍治疗方案基础上加用噻唑烷二酮类或磺脲类药物治疗的患者血糖控制继发失败。
Am J Manag Care. 2007 Aug;13(8):457-63.
5
Effects of troglitazone in patients with type 2 diabetes mellitus not adequately controlled by sulfonylureas.曲格列酮对磺脲类药物控制不佳的2型糖尿病患者的疗效。
Diabetes Res Clin Pract. 2001 Feb;51(2):151-3. doi: 10.1016/s0168-8227(00)00218-7.
6
Triple therapy with glimepiride in patients with type 2 diabetes mellitus inadequately controlled by metformin and a thiazolidinedione: results of a 30-week, randomized, double-blind, placebo-controlled, parallel-group study.对于二甲双胍和噻唑烷二酮治疗控制不佳的2型糖尿病患者，使用格列美脲进行三联疗法：一项为期30周的随机、双盲、安慰剂对照、平行组研究的结果。
Clin Ther. 2005 Oct;27(10):1535-47. doi: 10.1016/j.clinthera.2005.10.017.
7
Loss of glycemic control in patients with type 2 diabetes mellitus who were receiving initial metformin, sulfonylurea, or thiazolidinedione monotherapy.接受初始二甲双胍、磺脲类药物或噻唑烷二酮单药治疗的2型糖尿病患者血糖控制不佳。
Pharmacotherapy. 2007 Aug;27(8):1102-10. doi: 10.1592/phco.27.8.1102.
8
Effects of thiazolidinediones and sulfonylureas in patients with diabetes.噻唑烷二酮类药物和磺酰脲类药物对糖尿病患者的影响。
Diabetes Technol Ther. 2010 Jun;12(6):491-501. doi: 10.1089/dia.2009.0172.
9
Exploring Clinical Care Among Adults With Diabetes Mellitus: Alignment With Recommended Statin and Sulfonylureas Treatment.探索成年糖尿病患者的临床护理：与推荐的他汀类药物和磺酰脲类药物治疗的一致性。
Can J Diabetes. 2019 Oct;43(7):498-503. doi: 10.1016/j.jcjd.2019.04.008. Epub 2019 Apr 26.
10
Association of diet alone, insulin, sulfonylureas, metformin, and thiazolidinediones with the severity of coronary artery disease in patients with diabetes mellitus.单纯饮食、胰岛素、磺脲类药物、二甲双胍和噻唑烷二酮类药物与糖尿病患者冠状动脉疾病严重程度的关联。
Am J Ther. 2006 Sep-Oct;13(5):400-3. doi: 10.1097/01.mjt.0000208276.65249.1b.

本文引用的文献

1
Mortality among veterans with type 2 diabetes initiating metformin, sulfonylurea or rosiglitazone monotherapy.2 型糖尿病退伍军人起始使用二甲双胍、磺酰脲类或罗格列酮单药治疗的死亡率。
Diabetologia. 2013 Sep;56(9):1934-43. doi: 10.1007/s00125-013-2958-1. Epub 2013 Jun 25.
2
Emerging analytical techniques for comparative effectiveness research.用于比较效果研究的新兴分析技术。
Am J Kidney Dis. 2013 Jan;61(1):13-7. doi: 10.1053/j.ajkd.2012.08.030. Epub 2012 Sep 26.
3
Matching methods for causal inference: A review and a look forward.因果推断的匹配方法：综述与展望
Stat Sci. 2010 Feb 1;25(1):1-21. doi: 10.1214/09-STS313.
4
Balance diagnostics for comparing the distribution of baseline covariates between treatment groups in propensity-score matched samples.平衡诊断用于比较倾向评分匹配样本中治疗组间基线协变量的分布。
Stat Med. 2009 Nov 10;28(25):3083-107. doi: 10.1002/sim.3697.
5
Rosiglitazone is associated with mortality in chronic hemodialysis patients.罗格列酮与慢性血液透析患者的死亡率相关。
J Am Soc Nephrol. 2009 May;20(5):1094-101. doi: 10.1681/ASN.2008060579. Epub 2009 Apr 8.
6
Thiazolidinedione use is associated with better survival in hemodialysis patients with non-insulin dependent diabetes.噻唑烷二酮类药物的使用与非胰岛素依赖型糖尿病血液透析患者的更好生存率相关。
Kidney Int. 2009 May;75(9):961-8. doi: 10.1038/ki.2009.4. Epub 2009 Feb 4.
7
Insulin resistance accelerates muscle protein degradation: Activation of the ubiquitin-proteasome pathway by defects in muscle cell signaling.胰岛素抵抗加速肌肉蛋白质降解：肌肉细胞信号缺陷激活泛素-蛋白酶体途径。
Endocrinology. 2006 Sep;147(9):4160-8. doi: 10.1210/en.2006-0251. Epub 2006 Jun 15.
8
Effects of rosiglitazone alone and in combination with atorvastatin on nontraditional markers of cardiovascular disease in patients with type 2 diabetes mellitus.罗格列酮单独及与阿托伐他汀联合应用对2型糖尿病患者心血管疾病非传统标志物的影响。
Am J Cardiol. 2006 Mar 1;97(5):646-50. doi: 10.1016/j.amjcard.2005.09.101. Epub 2006 Jan 9.
9
Effect of rosiglitazone treatment on soluble CD40L in patients with type 2 diabetes and coronary artery disease.罗格列酮治疗对2型糖尿病合并冠状动脉疾病患者可溶性CD40L的影响。
Circulation. 2003 Apr 22;107(15):1954-7. doi: 10.1161/01.CIR.0000069272.06194.91. Epub 2003 Apr 14.

Thiazolidinedione use is associated with improved all-cause mortality compared with sulfonylureas among diabetic hemodialysis patients.

作者信息

Lynch Katherine E, Rhee Connie M, Brunelli Steven M

机构信息

Division of Nephrology, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA; Division of Nephrology, Brigham and Women's Hospital, Boston, Massachusetts, USA.

出版信息

J Diabetes. 2014 Jul;6(4):381-3. doi: 10.1111/1753-0407.12115. Epub 2014 Feb 13.

DOI:10.1111/1753-0407.12115
PMID:24330089
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4047208/
Abstract
摘要